Clinical Trials Directory

Trials / Completed

CompletedNCT01663363

Safety and Effectiveness of Wavefront-Guided LASIK Corrections of Myopic Refractive Errors

A Prospective Study to Evaluate the Safety and Effectiveness of Wavefront-Guided LASIK Correction of Myopic Refractive Errors With the iDesign Advanced Wavescan Studio™ System and Star S4IR™ Excimer Laser

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
170 (actual)
Sponsor
Abbott Medical Optics · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of this clinical trial is to demonstrate that wavefront-guided LASIK is safe and effective for the correction of myopic refractive errors.

Conditions

Interventions

TypeNameDescription
DEVICELASIK correction of myopic refractive errorsSurgeons will perform wavefront-guided LASIK based upon measurement obtained with the iDesign System

Timeline

Start date
2012-08-01
Primary completion
2014-03-01
Completion
2015-07-01
First posted
2012-08-13
Last updated
2025-02-04
Results posted
2015-06-26

Source: ClinicalTrials.gov record NCT01663363. Inclusion in this directory is not an endorsement.

Safety and Effectiveness of Wavefront-Guided LASIK Corrections of Myopic Refractive Errors (NCT01663363) · Clinical Trials Directory